Survival paradox between stage IIB/C (T4N0) and stage IIIA (T1-2N1) colon cancer. Ann Surg Oncol. 2015;22:505-512.Kim MJ, Jeong SY, Choi SJ, Ryoo SB, Park JW, Park KJ, et al. Survival paradox between stage IIB/C (T4N0) and stage IIIA (T1-2N1) colon cancer. Ann Surg ...
Diet: Whether diet plays a role in developing colon cancer remains under debate. The belief that a high-fiber, low-fat diet could help prevent colon cancer has been questioned. Studies do indicate thatexerciseand a diet rich in fruits and vegetables can help prevent colon cancer. Obesity: Obe...
- 《European Journal of Cancer》 被引量: 0发表: 2021年 Diagnostic performance of MRI- versus MDCT-categorized T3cd/T4 for identifying high-risk stage II or stage III colon cancers: a pilot study PurposeThe aim of this study was to determine the diagnostic performance of magnetic resonance ...
Getting diagnosed with stage 3 colon cancer in 2020 How stress was part of Fred’s cancer story The psychological impact of a cancer diagnosis The 3 concepts Fred adopted after he was diagnosed with cancer Why Fred initially declined the conventional cancer protocol and started fasting Finding out...
Clinical Significance of the Metastatic Lymph-Node Ratio in N2 Stage Colon Cancer The number of lymph nodes retrieved from the specimen may be a surrogate measure of the adequacy of extensive colon cancer surgery, but many variables may ... JK Min,Hyoung-Chul Park,BH Lee,... - 대한...
Prediction of overall survival in stage II and III colon cancer through machine learning of rapidly-acquired proteomics Kailun Xu Xiaoyang Yin Yingkuan Shao CorrespondenceOpen Access13 Aug 2024Cell Discovery Volume: 10, P: 85 Western lifestyle, metaflammation and the cell of origin of colon cance...
Estimates the cost-effectiveness of combined levamisole and fluorouracil as adjuvant treatment for patients with stage three colon cancer. Calculations on the cost of treatment; Negligible effect of quality-of-life adjustments on the cost-effectiveness outcome; Recommendation for adjuvant therapy as a cos...
ADJUVANT THERAPY FOR STAGE III COLON CANCER. 来自 Semantic Scholar 喜欢 0 阅读量: 18 作者: C. Mulrow 摘要: Most patients with colon carcinoma present with resectable disease in which any residual tumor is microscopic. This multicenter trial evaluated the efficacy of two adjuvant regimens for ...
Colorectal cancer (CRC) is the third most common cancer worldwide. Accurately identifying stage II CRC patients at risk for recurrence is an unmet clinical need. KCNQ1 was previously identified as a tumour suppressor gene and loss of expression was assoc
Marginal survival curvesa for initiation or no initiation of adjuvant chemotherapy ≤12 weeks of surgical resection for stage III colon cancer patients. A Overall survival. B Disease-free survival. (Adjusted for age, sex, race/ethnicity, insurance status, marital status, National Cancer Institue ...